SCHEMBL911135

SCHEMBL911135

CCCCCCCCOBOCCCCCCCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.47
TSHR P16473 1/20 0.47
MEN1 O00255 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 1/20 0.42
CA1 P00915 8/20 0.41
CA2 P00918 8/20 0.41
CA9 Q16790 7/20 0.41
LPAR3 Q9UBY5 6/20 0.41
LPAR2 Q9HBW0 5/20 0.41
CA12 O43570 3/20 0.41
CA7 P43166 3/20 0.41
CA14 Q9ULX7 3/20 0.41
LPAR1 Q92633 2/20 0.41
CA3 P07451 2/20 0.41
CA4 P22748 2/20 0.41
CA6 P23280 2/20 0.41
CA5A P35218 2/20 0.41
CA5B Q9Y2D0 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6805213 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL9221661 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL187269 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL3332706 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL21581247 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL493840 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL1149381 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL6909601 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL14688826 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL10240 0.97 THRB (0.41) THRBTSHRMEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8921299-B2 Detergents having acceptable color THE PROCTER & GAMBLE COMPANY (US) 2014-12-30 US claimed
WO-1995005081-A1 BIOCIDAL COMPOSITIONS CONTAINING ORGANOBORON COMPOUNDS U.S. BORAX INC. (US) 1995-02-23 WO claimed
US-20260109131-A1 CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES PROCTER & GAMBLE (US) 2026-04-23 US disclosed
US-20260110139-A1 CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES PROCTER & GAMBLE (US) 2026-04-23 US disclosed
US-12589103-B2 Antimicrobial and antiviral effects of C2-C7 alkyl boronic acids CORNELL UNIVERSITY (US) 2026-03-31 US disclosed
EP-4697957-A1 COMPOSITION COMPRISING AN ANTIMICROBIAL AGENT AND AN ALKOXYLATED AMINE BASF SE (DE) 2026-02-25 EP disclosed
US-12522813-B2 Mannanase for formulations having pH 5-12 BASF SE (DE) 2026-01-13 US disclosed
EP-4638687-A2 DETERGENT COMPOSITION COMPRISING CATALASE AND AMYLASE Novozymes A/S (DK) 2025-10-29 EP disclosed
EP-4634219-A1 HIGH STRENGTH LIQUID PROTEASE FORMULATIONS Novozymes A/S (DK) 2025-10-22 EP disclosed
US-20250295120-A1 CLEANING METHOD, USE OF ENZYMES AND CLEANING COMPOSITION NOVOZYMES A/S (DK) 2025-09-25 US disclosed
US-20250234861-A1 LACTONES FOR ENHANCING THE ACTIVITY OF ANTIMICROBIAL AGENTS BASF SE (DE) 2025-07-24 US disclosed
US-20090209447-A1 CLEANING COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2009-08-20 US disclosed
WO-2008116915-A1 STABLE ENZYME SOLUTIONS AND METHOD OF MANUFACTURING NOVOZYMES A/S (DK) 2008-10-02 WO disclosed
WO-2008064337-A2 BENZOCYCLOHEPTYL ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE RECEPTOR ACTIVITY UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2008-05-29 WO disclosed
WO-2008064320-A2 HYDRINDANE ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST ACTIVITY UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2008-05-29 WO disclosed
WO-2008064315-A1 TETRALIN ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE AGONIST ACTIVITY UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2008-05-29 WO disclosed
EP-1924677-A1 STABILIZATION OF CONCENTRATED LIQUID ENZYME ADDITIVES Novozymes A/S (DK) 2008-05-28 EP disclosed
US-20070060493-A1 Stabilization of concentrated liquid enzyme additives NOVOZYMES A/S (DK) 2007-03-15 US disclosed
WO-2007025549-A1 STABILIZATION OF CONCENTRATED LIQUID ENZYME ADDITIVES NOVOZYMES A/S (DK) 2007-03-08 WO disclosed
WO-1995005081-A1 BIOCIDAL COMPOSITIONS CONTAINING ORGANOBORON COMPOUNDS U.S. BORAX INC. (US) 1995-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250234861-A1 LACTONES FOR ENHANCING THE ACTIVITY OF ANTIMICROBIAL AGENTS CYP51A1, LSS, OLA1 THRB 3871/4885TSHR 2676/4885MEN1 1481/4885
US-20250295120-A1 CLEANING METHOD, USE OF ENZYMES AND CLEANING COMPOSITION DNASE1, HEXD, HEXA THRB 4674/4885TSHR 3983/4885MEN1 1807/4885
US-12589103-B2 Antimicrobial and antiviral effects of C2-C7 alkyl boronic acids FABP2, TLR7, SLC10A2 THRB 583/4885TSHR 618/4885MEN1 998/4885
US-20260109131-A1 CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES VCAM1, PLOD3, TLN1 THRB 2786/4885TSHR 3112/4885MEN1 362/4885
US-20260110139-A1 CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES VCL, PLOD3, ILK THRB 2825/4885TSHR 3465/4885MEN1 674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.